BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2008
View Archived Issues
BioMarin reports Q4 and full-year 2007 results
Read More
Pipeline progress at Antigenics
Read More
Roche updates prescribing information for influenza drug Tamiflu
Read More
Advanced Cancer signs exclusive license with Brown Cancer Center for anticancer drug
Read More
Raven enters research collaboration with Emory University for prostate cancer stem cells
Read More
Cypress Bioscience closes acquisition of Proprius for USD 37.5 million in cash
Read More
E.U. Commission approves amended prescribing information for Aranesp
Read More
DiaMedica receives E.U. regulatory clearance for phase II study of DM-99 in type 2 diabetes
Read More
Celgene initiates phase I clinical study of inflammatory disease drug candidate
Read More
Microbia and Forest report preliminary results from two phase IIb studies of linaclotide
Read More
Promising PET radioligand profiled at the NIH
Read More
Neurokinin 1 receptor potential target for the treatment of alcoholism
Read More
Study reports new class of selective Plasmodium falciparum inhibitors
Read More
ActivBiotics receives FDA orphan drug designation for M-40403 in oral mucositis
Read More
EpiCept earns milestone payment from Myriad Genetics for progress in phase II trial of Azixa
Read More
Oral PSI-421 treatment effective in primate model of deep vein thrombosis
Read More
FDA accepts for review Theravance's response to NDA approvable letter for telavancin
Read More
Evotec signs second drug discovery contract with InterMune
Read More
New agents for treating urolithiasis disclosed in recent University of Western Ontario patent
Read More
FDA agrees with remaining two protocols for Alizyme's phase III clinical studies of cetilistat
Read More
Novel antiinfective agents described in recent patent literature
Read More
Recent patents divulge new antipsychotic agents
Read More
GenVec receives a phase I grant from the NIAID for adenovector-based vaccines for HSV-2
Read More
Avanir licenses anthrax monoclonal antibody program to Emergent BioSolutions
Read More
Genzyme launches Renvela in the U.S. for dialysis patients and submits MAA to the EMEA
Read More
CSL Behring submits BLA to the FDA for Berinert in hereditary angioedema
Read More